Regional Health Headlines
Today is September 20, 2024. All times in Eastern Daylight Time.
Infinity Bio Unveils the World’s Most Comprehensive Autoantibody Analysis Service: HuSIGHT-Total™
09/17/2024 - 12:07 PM
Summit Health Opens Two New Multispecialty Healthcare Facilities in Fair Lawn and Bridgewater, N.J.
09/17/2024 - 11:41 AM
Sapio Sciences Partner Program Welcomes Astrix
09/17/2024 - 09:06 AM
G&A Partners Increases Presence in District of Columbia, Virginia, and Maryland Markets
09/17/2024 - 09:00 AM
Mid Atlantic Radiology Consultants Contracts with Healthcare Administrative Partners for Comprehensive Revenue Cycle Services
09/17/2024 - 08:37 AM
Tris Pharma Promotes Manesh Naidu to Chief Commercial Officer
09/17/2024 - 08:30 AM
Global Medical REIT Announces Lease with CHRISTUS Health at its Facility in Beaumont, Texas
09/17/2024 - 08:00 AM
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
09/17/2024 - 07:00 AM
Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
09/17/2024 - 07:00 AM
Adbry® (tralokinumab-ldrm) Autoinjector Now Available for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis (AD) in the U.S.
09/17/2024 - 06:45 AM
Patritumab Deruxtecan Demonstrated Statistically Significant Improvement in Progression-Free Survival Versus Doublet Chemotherapy in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer in HERTHENA-Lung02 Phase 3 Trial
09/17/2024 - 06:00 AM
LabVantage Solutions Partners with Henkel on New Integrated Platform to Drive R&D Digital Transformation
09/17/2024 - 05:00 AM
Hackensack Meridian Health is Redefining Primary Care Through Partnership with K Health
09/16/2024 - 09:00 AM
’Tis the Season to Cash Back with Chase Freedom® Q4 2024 Categories: McDonald’s, PayPal, Pet Shops & Vet Services and Select Charities
09/16/2024 - 08:00 AM
AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt
09/16/2024 - 08:00 AM
UroGen Receives New U.S. Patent Allowance for Next-Generation Mitomycin-Based Products Expected to Provide Protection Until December 2041
09/16/2024 - 08:00 AM
IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) demonstrated unprecedented overall survival in advanced liver cancer with one in five patients surviving five years in HIMALAYA Phase III trial
09/16/2024 - 07:00 AM
ESMO 2024 Late-Breaking Data: Phase III ARANOTE Trial Shows NUBEQA® (darolutamide) Significantly Reduced Risk of Radiological Progression or Death in Metastatic Hormone-Sensitive Prostate Cancer
09/16/2024 - 04:30 AM
IMFINZI® (durvalumab) perioperative regimen reduced the risk of recurrence by 32% and the risk of death by 25% vs. neoadjuvant chemotherapy alone in muscle-invasive bladder cancer in the NIAGARA Phase III trial
09/15/2024 - 10:30 AM
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as Single Agent After Surgery Reduced Risk of Death by More Than One-Third (34%) Versus Neoadjuvant Chemotherapy in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)
09/15/2024 - 10:30 AM
Bristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed Continued Durable Long-Term Survival Benefit with Opdivo® plus Yervoy® in Advanced Melanoma
09/15/2024 - 08:55 AM
DS-9606 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors
09/15/2024 - 08:45 AM
Ten-Year Data for Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Sustained Overall Survival Benefit Versus Ipilimumab in Advanced Melanoma
09/15/2024 - 08:45 AM
Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer
09/14/2024 - 12:45 PM
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma
09/14/2024 - 10:35 AM
1
2
3
« Previous
Next »
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire
News
Industry News
News
Delaware Bio Observer
Press Releases
Featured Member
Delaware Bio Partners
Industry News